834 related articles for article (PubMed ID: 12494471)
21. Four novel MSH2 / MLH1 gene mutations in portuguese HNPCC families.
Isidro G; Veiga I; Matos P; Almeida S; Bizarro S; Marshall B; Baptista M; Leite J; Regateiro F; Soares J; Castedo S; Boavida MG
Hum Mutat; 2000 Jan; 15(1):116. PubMed ID: 10612836
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.
Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E
Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650
[TBL] [Abstract][Full Text] [Related]
23. Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer.
Viel A; Genuardi M; Capozzi E; Leonardi F; Bellacosa A; Paravatou-Petsotas M; Pomponi MG; Fornasarig M; Percesepe A; Roncucci L; Tamassia MG; Benatti P; Ponz de Leon M; Valenti A; Covino M; Anti M; Foletto M; Boiocchi M; Neri G
Genes Chromosomes Cancer; 1997 Jan; 18(1):8-18. PubMed ID: 8993976
[TBL] [Abstract][Full Text] [Related]
24. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
25. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
[TBL] [Abstract][Full Text] [Related]
27. Four novel MSH2 and MLH1 frameshift mutations and occurrence of a breast cancer phenocopy in hereditary nonpolyposis colorectal cancer.
Caluseriu O; Cordisco EL; Viel A; Majore S; Nascimbeni R; Pucciarelli S; Genuardi M
Hum Mutat; 2001 Jun; 17(6):521. PubMed ID: 11385712
[TBL] [Abstract][Full Text] [Related]
28. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC.
Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK
Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996
[TBL] [Abstract][Full Text] [Related]
29. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.
Wu Y; Berends MJ; Mensink RG; Kempinga C; Sijmons RH; van Der Zee AG; Hollema H; Kleibeuker JH; Buys CH; Hofstra RM
Am J Hum Genet; 1999 Nov; 65(5):1291-8. PubMed ID: 10521294
[TBL] [Abstract][Full Text] [Related]
30. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing.
Christensen M; Katballe N; Wikman F; Primdahl H; Sørensen FB; Laurberg S; Ørntoft TF
Cancer; 2002 Dec; 95(11):2422-30. PubMed ID: 12436451
[TBL] [Abstract][Full Text] [Related]
31. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
Shin KH; Shin JH; Kim JH; Park JG
Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of microsatellite markers in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families.
Smolarz B; Romanowicz-Makowska H; Langner E; Kozlowska E; Kulig A; Dziki A
Exp Oncol; 2004 Sep; 26(3):205-9. PubMed ID: 15494688
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques.
Nakagawa H; Hampel H; de la Chapelle A
Hum Mutat; 2003 Sep; 22(3):258. PubMed ID: 12938096
[TBL] [Abstract][Full Text] [Related]
35. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
[TBL] [Abstract][Full Text] [Related]
36. Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability.
Herfarth KK; Kodner IJ; Whelan AJ; Ivanovich JL; Bracamontes JR; Wells SA; Goodfellow PJ
Genes Chromosomes Cancer; 1997 Jan; 18(1):42-9. PubMed ID: 8993979
[TBL] [Abstract][Full Text] [Related]
37. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
[TBL] [Abstract][Full Text] [Related]
38. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA.
Taylor CF; Charlton RS; Burn J; Sheridan E; Taylor GR
Hum Mutat; 2003 Dec; 22(6):428-33. PubMed ID: 14635101
[TBL] [Abstract][Full Text] [Related]
39. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
[TBL] [Abstract][Full Text] [Related]
40. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
